You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Bowel Obstruction, Docetaxel, Oxaliplatin, 5-Fluorouracil

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Gastric Adenocarcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma Trial in Guangzhou (Docetaxel,

Recruiting
  • Metastatic Gastric Adenocarcinoma
  • Metastatic Gastroesophageal Junction Adenocarcinoma
  • Guangzhou, Guangdong, China
    The Sixth Affiliated hosipital, Sun Yat-Sen University
Jan 20, 2022

Gastric Cancer, Stomach Cancer, GastroEsophageal Cancer Trial in Kyiv (Docetaxel, Oxaliplatin, Leucovorin)

Recruiting
  • Gastric Cancer
  • +10 more
  • Kyiv, Ukraine
    National Cancer Institute
Aug 31, 2023

Peritoneal Carcinomatosis Trial in Baltimore (Intraperitoneal docetaxel)

Recruiting
  • Peritoneal Carcinomatosis
  • Intraperitoneal docetaxel
  • Baltimore, Maryland
    Johns Hopkins University
Nov 7, 2022

Gastric Cancer Trial in Seoul (Docetaxel (XRP6976), Oxaliplatin (SR96669), S-1 (1-(2-tetrahydrofuryl)-5-fluorouracil +

Active, not recruiting
Has Results
  • Gastric Cancer
  • Docetaxel (XRP6976)
  • +2 more
  • Seoul, Korea, Republic of
    Administrative Office
May 3, 2022

Resectable Gastric or Gastroesophageal Junction Adenocarcinoma Trial (Cadonilimab, AK117, Oxaliplatin)

Not yet recruiting
  • Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
  • (no location specified)
Jul 17, 2023

Cervical Esophagus Adenocarcinoma, Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage IIA Esophageal

Recruiting
  • Cervical Esophagus Adenocarcinoma
  • +12 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 31, 2022

Gastric Cancer Trial in Frankfurt am Main (5-Fluorouracil, Leucovorin, Oxaliplatin)

Recruiting
  • Gastric Cancer
  • Frankfurt am Main, Germany
    Krankenhaus Nordwest
Feb 21, 2022

Pancreatic Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Adenocarcinoma Trial in Chicago (Oxaliplatin, Docetaxel,

Recruiting
  • Pancreatic Adenocarcinoma
  • +2 more
  • Chicago, Illinois
    The University of Chicago
Jun 7, 2021

Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage II Gastric Cancer AJCC v8, Clinical Stage II Gastroesophageal Junction

Not yet recruiting
  • Clinical Stage I Gastric Cancer AJCC v8
  • +9 more
  • Atezolizumab
  • +12 more
  • (no location specified)
Apr 26, 2023

Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, HER2-positive Gastric Cancer Trial in China

Not yet recruiting
  • Adenocarcinoma of the Stomach
  • +2 more
  • Hangzhou, Zhejiang, China
  • +7 more
Feb 7, 2023

Treated by Neo-adjuvant Combination of Oxaliplatin, Irinotecan,

Recruiting
  • Liver Metastasis Colon Cancer
  • Synchronous Neoplasm
  • Neo-adjuvant Chemotherapy FOLFOXIRI Regimen
  • synchronous resection surgery
  • Ho Chi Minh City, Vietnam
    Cho Ray hospital- 201 B Nguyen Chi Thanh, District 5
May 5, 2022

Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage II Gastric Cancer AJCC v8, Clinical Stage IIA Gastric Cancer AJCC v8

Not yet recruiting
  • Clinical Stage I Gastric Cancer AJCC v8
  • +24 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Mar 15, 2022

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Frankfurt, Bern (Atezolizumab, 5-Fluorouracil, Calciumfolinat)

Active, not recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Frankfurt, Germany
  • +1 more
Apr 14, 2022

Chemo, Gastric Cancer Trial in Guangzhou (FLOT(Docetaxel+oxaliplatin+leucovorin+5-FU), Treprizumab, Tiggio capsule (S-1))

Recruiting
  • Chemotherapy
  • Gastric Cancer
  • FLOT(Docetaxel+oxaliplatin+leucovorin+5-FU), Treprizumab, Tiggio capsule (S-1)
  • Guangzhou, Guangdong, China
    Guangdong Province Hospital of Chinese Medicine, the Second Affi
May 10, 2021

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Houston (Fluorouracil, Leucovorin, Oxaliplatin)

Not yet recruiting
  • Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • Houston, Texas
  • +3 more
Nov 13, 2022

Advanced Solid Tumors, Colorectal Cancer, Non Small Cell Lung Cancer Trial in France, Spain (CAN04 (nadunolimab), mFOLFOX, DTX)

Active, not recruiting
  • Advanced Solid Tumors
  • +3 more
  • CAN04 (nadunolimab)
  • +3 more
  • Saint-Herblain, Boulevard Jacques Monod, France
  • +5 more
Oct 20, 2022

Gastric Cancer Trial in Australia, New Zealand (drug, radiation, procedure)

Active, not recruiting
  • Gastric Cancer
  • Epirubicin + cisplatin + 5-fluorouracil OR epirubicin + cisplatin + capecitabine OR epirubicin + oxaliplatin + capecitabine OR 5-Fluorouracil + leucovorin + oxaliplatin + docetaxel
  • +2 more
  • Newcastle, New South Wales, Australia
  • +22 more
Mar 21, 2022

Gastric Cancer Trial in Mykolaiv (Docetaxel, Oxaliplatin, Leucovorin)

Active, not recruiting
  • Gastric Cancer
  • Mykolaiv, Ukraine
    Ukrainian Society of Clinical Oncology
Apr 11, 2022

Esophageal Cancer, Adenocarcinoma, Esophageal, Adenocarcinoma, Gastroesophageal Junction Trial in Winnipeg, London, Toronto

Recruiting
  • Esophageal Cancer
  • +2 more
  • (Epirubicin Cisplatin 5-Fluorouracil / Xeloda) OR 5-Fluorouracil Leucovorin Oxaliplatin Docetaxel
  • Carboplatin paclitaxel plus concurrent radiotherapy
  • Winnipeg, Manitoba, Canada
  • +2 more
Mar 29, 2021

Gastric Cancer, Adenocarcinoma of the Esophagogastric Junction Trial in Essen (Nivolumab, relatlimab, Oxaliplatin)

Recruiting
  • Gastric Cancer
  • Adenocarcinoma of the Esophagogastric Junction
  • Essen, Germany
    University Hospital Essen
May 18, 2021

Melanoma, Prostate Cancer, Ovarian Cancer Trial in United States (Pegilodecakin, Paclitaxel or Docetaxel and Carboplatin or

Active, not recruiting
  • Melanoma
  • +8 more
  • Los Angeles, California
  • +9 more
Nov 15, 2022

OESOPHAGO-GASTRIC CARCINOMA Trial in France, Martinique (Oxaliplatin, 5Fluorouracil bolus, 5Fluorouracil continu)

Recruiting
  • OESOPHAGO-GASTRIC CARCINOMA
  • Paris, Ile De France, France
  • +97 more
Mar 23, 2022

Esophageal Adenocarcinoma (UICC TNM7), Adenocarcinoma of the Esophagogastric Junction Trial in Germany (5-Fluorouracil,

Active, not recruiting
  • Esophageal Adenocarcinoma (UICC TNM7)
  • Adenocarcinoma of the Esophagogastric Junction
  • Aachen, Germany
  • +29 more
Nov 1, 2022

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Germany (5-Fluorouracil, Leucovorin, Oxaliplatin)

Recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Aachen, Germany
  • +14 more
Sep 7, 2022

Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction, Gastric

Completed
  • Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction
  • +5 more
  • S-1 de-escalation
  • Chemotherapy by Investigator's choice
  • Heidelberg, Baden-Württemberg, Germany
    NCT-Med. Onkologie
Mar 25, 2021